You have to wait all them years to be balling? Then again, you have to have big money to be a big time baller too. Good stocks like FB, apple, yahoo are the safest bet when buying at their infancy. Sure profit but right now, we all have missed the train. Everyone is looking for another fb and the likes to park their money. Less risky investment that way.
However, I know a guy who parks his 300K on them high volatile stock and when he sells, I too sell since he holds the larger bag and when he sells, stock prices will fall too. I get out when he gets out.
Like yesterday, my beloved amda had the hardest time going over that 80 cents marker. It had 5 million volumes in the first half hour alone then I saw her leveling out at 80 cents a share, around there. He said he take profit and banked 90K. I too sold with him then I about my business just to see amda down big time. Down you say? Well good, we both bought in again at the low low today and she is making us 12% right now. I'm selling her again when he does.
This day trading style to take nickle and change works for chart readers. Buy at the dip, sell at the tip or put a stop limit just in case and take profit. I love high volume that moves the price per shares all over the place. Hard to buy yes because it can not stop moving but it has the pump and dump theory behind it which then makes it perfect for me to get a strategy going with such stock.
I have been buying different stocks and holding and in hoping to be another FB but man, I don't have years upon years to double up. I play the high risk role with the right kind of strategy will get me double up in no time. Doubling up to a million. 
edit: Amda just hit 20% a few moment ago. 17% now. stop limit up and taking profit at 15%.
wait for her to go down more and enter again for another ride. Does FB gives me 15% profit on one sitting? Sure, I got to wait for another 3 months and that is an if.
edit 2: 24% now Stop limit up again. wow 
amda made me profit yes. I'm waiting for the low to enter her again. Her product already approved in the european market and is selling well. It just needs that approval by fda to sell here in the USA. It is not like it will get rejected because the product does not work. It is working in Europe like hello. News will come in the 3rd quarter and I believe we are in the 3rd quarter now.
I've been watching these MM driving this stock down. I hate MM but I have learned to love them and should thank them for driving it down so that I can buy it on the low low. Cheap to buy right now around 52 cents a share. Why not.
My futurist play book on
amda -If and when fda gives clearance to sell in the usa market, shares will go up due to expected earning revenues for the company goes up.
-Big companies may want to partnership or merge or buyout. Hit the jackpot if that happens. Due date is second half of 2016.
-Insiders are starting to buy so you know what that means. If they buy, we buy. They insiders, they know what's up and they want to make that money too.
Amedica Corporation Provides Update on FDA Questions and Femoral Head Testing Protocol Feedback
4:45 PM ET 7/7/15 | GlobeNewswire
Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced that responses to the U.S. Food and Drug Administration ("FDA") inquiries regarding the Company's cervical composite silicon nitride interbody device were submitted to the FDA on June 30, 2015. Additionally, the Company has received feedback from the FDA regarding its wear testing femoral head protocols.
Submission for 510(k) clearance of the Valeo C Interbody with CsC Osteo-Conductive Scaffolding ("Valeo C CsC"), which was submitted in the first quarter of 2015, relates to the Company's CASCADE clinical trial of its composite silicon nitride spinal interbody devices. Since submission, the Company received a list of questions from the FDA requesting additional information pertaining to the product's clinical performance data, as well as indications for use and device description. The Company has responded to the questions and now awaits clearance of the Class II medical device for commercial distribution or additional communication from the FDA.
"After successfully completing an important surveillance audit with no non-conformities being identified, we've submitted responses to the FDA questions regarding our composite silicon nitride device," said Dr. Sonny Bal, chairman and CEO of Amedica Corporation. "Our submission starts the clock once again with the FDA, and we remain hopeful for a final response during the third quarter of this year. As sales momentum of this unique device continues to build in Europe, we look forward to beginning domestic shipments as soon as we achieve clearance."
"We also received very constructive feedback on our proposed wear testing protocol and have a clearer understanding of the pathway to market for our silicon nitride femoral heads in the U.S.," continued Dr. Bal. "The comments by the FDA will ensure that the testing of our material, as compared to other ceramic predicate devices on the market, will meet or exceed existing testing standards. Silicon nitride is the toughest, most fracture resistant, chemically stable bioceramic available today. We look forward to a direct comparison to all other femoral head materials, which is slated to begin later this year, to confirm our claim that silicon nitride is the ideal biomaterial of choice."
Topic: We talk stock market here....... (Read 164349 times)